Pseudomonas aeruginosa (PA) is a globally prevalent opportunistic pathogen capable of causing a broad spectrum of bacterial conditions. Its emerging multidrug-resistant (MDRPA) and carbapenem-resistant (CRPA) strains, recognized as significant public health threats, boost mortality rates, healthcare costs, and impose substantial clinical challenges. This article discusses a retrospective cohort study determining risk factors for these hard-to-treat…